跳到主要內容

臺灣博碩士論文加值系統

(44.200.86.95) 您好!臺灣時間:2024/05/21 09:31
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:陳厚志
論文名稱:丹參酸及厚朴酚對大鼠胸主動脈平滑肌細胞增生的抑制作用
論文名稱(外文):The inhibitory effects of Salvianolic acid B and Magnolol on vascular smooth muscle cells proliferation
指導教授:吳介信吳介信引用關係
學位類別:碩士
校院名稱:中國醫藥學院
系所名稱:醫學研究所
學門:醫藥衛生學門
學類:醫學學類
論文種類:學術論文
論文出版年:2002
畢業學年度:90
語文別:中文
論文頁數:71
中文關鍵詞:丹參酸厚朴酚平滑肌細胞
外文關鍵詞:Salvianolic acid BMagnololvascular smooth muscle cells
相關次數:
  • 被引用被引用:4
  • 點閱點閱:179
  • 評分評分:
  • 下載下載:36
  • 收藏至我的研究室書目清單書目收藏:1
根據衛生署統計心臟疾病是國人十大死因之一,其中冠狀動脈阻塞佔了大部份。目前對於冠狀動脈阻塞的治療大多施以血管擴張術 (angioplasty) 或血管繞道手術 (surgical bypass grafting) ,近年發展的經皮穿腔冠狀動脈血管成形術(percutaneous transluminal coronary angioplasty, PTCA) 及支架置入方法可以不經開心手術即可達到治療的效果,對冠狀動脈治療助益頗多。在美國一年有約 40 萬件的血管擴張術病例,而這些病例中約 30~50% 在六個月後會發生血管再阻塞現象而必須再次接受血管擴張術,在國內比例則更高。這對病患及其家屬造成很大的心理及經濟上的負擔。其中平滑肌細胞不正常的增生是造成再阻塞現象的主因之一。
因此我們利用傳統中藥丹參萃取物salvianolic acid B 及厚朴萃取物magnolol對大鼠胸主動脈平滑肌細胞進行in vitro的實驗。在細胞增生實驗的結果看來0.05mg/ml的magnolol對PCNA的表達及DNA合成有抑制的作用;而salvianolic acid B則無效果。不過二者對RB和FAK沒有影響。在探討藥物是否引起細胞凋亡的實驗中,western blot的結果顯示 salvianolic acid B和magnolol明顯的引發RIP及caspase-3的表達。另外,0.1mg/ml salvianolic acid B 能抑制NF-κB promoter的活性。在抗氧化實驗中,salvianolic acid B和magnolol明顯的減少大鼠血清中MDA的產生。
根據這些結果,我們認為salvianolic acid B和magnolol 對平滑肌細胞的增生有抑制作用。salvianolic acid B可能經由抑制NF-κB引起細胞凋亡。Magnolol 則是抑制細胞進入細胞週期中的S

There are approximately 250,000 people suffered from restenosis 6 months after percutaneous transluminal coronary angioplasty (PTCA) every year in the USA. One of the pathological mechanisms of restenosis has been attributed to abnormal proliferation of vascular smooth muscle cells. The aim of our study was to investigate the effect of Salvianolic B and Magnolol to inhibit proliferation of vascular smooth muscle cells and the mechanisms underlying the action of Salvianolic B and Magnolol. A10 cells, rat aortic smooth muscle cells,was used in this study to clarify these issues. From the in vitro result of western blot using antibody against PCNA and BrdU incorporation assay, we observed that 0.05mg/ml Magnolol significantly inhibit the proliferation of rat aortic smooth muscle cells. Whereas Magnolol demonstrated the inhibitory effects on BrdU incorporation in a dose-dependent manner; Salvianolic B did not show innibitory effect of vascular smooth muscle cells proliferation. In our study, we also evaluate the proteins that related to RIP and caspase-3 can be affected by Salvianolic B and Magnolol. It was found that the protein level of RIP and caspase-3 was significantly induced by Salvianolic B and Magnolol. On the other hand, Salvianolic B could inhibit the activity of NF-κB promoter. These results suggest that the proliferation of SMC can be regulated by Salvianolic B and Magnolol. Although PCNA protein level can be affectd by Magnolol, but we did not observe significant effect of Magnolol on P27 and RB protein expression level.

目錄…………………………………………………………………… 1
圖次…………………………………………………………………… 2
符號與縮寫…………………………………………………………… 3
中文摘要……………………………………………………………… 5
第一章 前言………………………………………………………… 7
第二章 實驗材料…………………………………………………… 24
第三章 實驗方法…………………………………………………… 28
第四章 實驗結果(含圖)………………………………………… 38
第五章 討論………………………………………………………… 52
第六章 參考文獻…………………………………………………… 57
英文摘要……………………………………………………………… 70

[1] Faxon DP.(1993) Restenosis after angioplasty: what have we learned from clinical trail? Cardiol Rev 1:209-217.
[2] Kuntz R.E., Baim D.S.(1993) Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation 88:1310-1323.
[3] Serruys P.W., Foley D.P., (1993) Kirkeeide R.L.,King S.B. Restenosis revisited: insights provided by quantitative coronary angioplasty. Am Heart J 126:1243-1267. Editorial.
[4] MJ Post, C Borst, and RE Kuntz. (1994) The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 89:2816-2821.
[5] Antoine Lafont, Luis A. Guzman, Patrick L. Whitlow, Marlene Goormastic, J. Fredrick Cornhill, and Guy M. Chisolm. (1995) Restenosis After Experimental Angioplasty : Intimal, Medial, and Adventitial Changes Associated With Constrictive Remodeling. Circ Res 76:996-1002.
[6] Yi Shi, Marc Pieniek, Ali Fard, James O'Brien, John D. Mannion, and Andrew Zalewski. (1996) Adventitial Remodeling After Coronary Arterial Injury. Circulation 93:340-348.
[7] Henning Rud Andersen, Michael Mæng, Martin Thorwest, and Erling Falk. (1996) Remodeling Rather Than Neointimal Formation Explains Luminal Narrowing After Deep Vessel Wall Injury : Insights From a Porcine Coronary (Re)stenosis Model. Circulation 93:1716-724.
[8] Schwartz RS. Edwards WD. Huber KC. Antoniades LC. Bailey KR. Camrud AR. Jorgenson MA. Holmes DR Jr. (1993) Coronary restenosis: prospects for solution and new perspectives from a porcine model.Mayo Clinic Proceedings. 68:54-62.
[9] Carter AJ. Laird JR. Farb A. Kufs W. Wortham DC. Virmani R. (1994) Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 24:1398-405.
[10] Lam JY. Chesebro JH. Steele PM. Dewanjee MK. Badimon L. Fuster V. (1986) Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol 8:1380-6.
[11] Ip JH. Fuster V. Israel D. Badimon L. Badimon J. Chesebro JH.
The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991;17(6 Suppl B):77B-88B
[12] Meyer BJ. Fernandez-Ortiz A. Mailhac A. Falk E. Badimon L. Michael AD. Chesebro JH. Fuster V. Badimon JJ. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation 1994;90:2474-80.
[13] Crowley ST. Ray CJ. Nawaz D. Majack RA. Horwitz LD. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol 1995;269(5 Pt 2):H1641-7,
[14] Ward Casscells, MD Migration of smooth muscle and endothelial cells. Critical events in restenosis Circulation 86;3:723-9
[15] Schwartz SM, Heimark RL, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev 1990;70:177-209.
[16] Clowes AW, Reidy MA J Vasc Surg 1991;13:885-891.
[17] Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 6:369 —375.
[18] Uchida Y, Hasegawa K, Kawamura K, Shibuya I. Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplasty. Am Heart J 1989;117:769 —776.
[19] Block PC. Restenosis after percutaneous transluminal coronary angioplasty─anatomic and pathophysiological mechanisms: strategies for prevention. Circulation 1990;81:IV2—IV4.
[20] Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Virmani R. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44 —52.
[21] Rogers C, Parikh S, Seifert P, Edelman ER. Endogenous cell seeding: remnant endothelium after stenting enhances vascular repair. Circulation 1996; 94:2909 —2914.
[22] Nugent HM, Rogers C, Edelman ER. Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res 1999;84:384 —391.
[23] Gajdusek C, Carbon S, Ross R, Nawroth P, Stern D. Activation of coagulation releases endothelial cell mitogens. J Cell Biol 1986;103:419-428.
[24] Koo EWY, Gotlieb AI Lab Invest 1991;64:743-750.
[25] Wight TN Arteriosclerosis 1989;9:1-20.
[26] Dzau VJ, Gibbons GH Hypertension 1991;18:15-21.
[27] Antonelli-Orlidge A, Saunders KB, Smith SR, D’Amore PA. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 1989;86:4544-4548.
[28] Herman IM, Castellot JJ Jr Arteriosclerosis 1987;7:463-469.
[29] Neumann FJ, Ott I, Gawaz M, Puchner G, Schomig A. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing an-gioplasty. J Am Coll Cardiol 1996;27:819 —824.
[30] Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neoin-timal hyperplasia. J Am Coll Cardiol 1998;31:224 —230.
[31] Rogers C, Welt FG, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits: coupled inhibitory effects of heparin. Arterioscl Thromb Vasc Biol 1996;16:1312—1318.
[32] Rogers C, Edelman ER, Simon DI. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA 1998;95:10134 —10139.
[33] Simon DI, Chen Z, Seifert P, Edelman E, Ballantyne CM, Rogers C. Markedly reduced neointimal thickening in Mac-1 (CD11b/CD18)-deficient mice after carotid artery dilation and endothelial denudation (abstract). Circulation 1998;98:I-238.
[34] Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Ramazzotti V, Rebuzzi AG, Crea F, Maseri A. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999;34:1512—1521.
[35] Laurindo FRM, da Luz PL, Uint L et al. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation 1991;83:1705—1715.
[36] Nunes GL, Sgoutas DS, Redden RA et al. Combinations of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol 1995;15:156—165.
[37] Nunes GL, Robinson K, Kalynych A et al. Vitamins C and E inhibit O2-production in pig coronary arteries. Circulation 1997;89:3593- 3601.
[38] Ferns GA, Forster L, Stewart-Lee A et al. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc Natl Acad Sci USA 1992; 89:11312—11316.
[39] Freyschuss A, Stiko RA, Swedenborg J et al. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest 1993;91:1282—1288.
[40] Schneider JE, Berk BC, Gravanis MB et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation 1993;88:627—628.
[41] Miyauchi K, Aikawa M, Tani T et al. Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: possible role of PDGF. Cardiovasc Drugs Ther 1998;12:251—260.
[42] Tanaka K, Hayashi K, Shingu T et al. Probucol inhibits neointimal formation in carotid arteries of normocholesterolemic rabbits and the proliferation of cultured rabbit vascular smooth muscle cells. Cardiovasc Drugs Ther 1998;12:19—28.
[43] Tardif JC, Cote G, Lesperance J et al. Probucol and multivitamins in the prevention of reestenosis after coronary angioplasty. N Engl J Med 1997;337:365—372.
[44] Lee YJ, Daida H, Yokoi H et al. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty. Jpn Heart J 1996;37:327—332.
[45] Setsuda M, Inden M, Hiraoka N et al. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty. Clin Ther 1993;15:374—382.
[46] Yokoi H, Daida H, Kuwabara Y et al. Effectiveness of an anti-oxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol 1997;30:855—862.
[47] Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Hashida H. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1996;132:23—29.
[48] O’Keefe Jr. JH, Stone GW, McCallister Jr. BD et al. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1996;77:649—652.
[49] Sekiya M, Funada J, Watanabe K, Miyagawa M, Akutsu H. Effects of probucol and cilostazol alone and in combination on frequency of post-stenting restenosis. Am J Cardiol 1998;82:144—147.
[50] Rodes J, Cote G, Lesperance J et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation 1998;97:429—436.
[51] Rao, G. N.; Berk, B. C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 1992;70:593—599.
[52] Marui, N.; Offermann, N. K.; Swerlick, R.; Kunsch, C.; Rosen, A.; Ahmad, M.; Alexander, R. W.; Medford, R. M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expres-sion are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 1993;92:1866—1874.
[53] Arbault S, Pantano P, Sojic N et al. Activation of the NADPH oxidase in human fibroblasts by intrusion of a single cell with an ultramicroelectrode. Carcinogenesis 1997;18:569—574.
[54] Abe JI, Berk BC. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med 1998;8:59—63.
[55] Susuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997;22:269—285.
[56] Sen CK, Packer L. Antioxidant and redox regulation of gene expression. FASEB J 1996;10:709—720.
[57] Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753—766.
[58] Souza HP, Souza LC, Anastacio VM, et al. Vascular oxidant stress early after balloon injury. Evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med 2000;in press.
[59] Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. Circ Res 1999;84:113—121.
[60] Yi Shi, Marc Pieniek, Ali Fard, James O'Brien, John D. Mannion, and Andrew Zalewski Adventitial Remodeling After Coronary Arterial Injury. Circulation 1996;93: 340-348
[61] Hogeman B, Gillessen A, Bocker W, Rauterberg J, Domschke W. Myofibroblast-like cells produce mRNA for type I and III procollagens in chronic active hepatitis. Scand J Gastroenterol.. 1993;28:591-594.
[62] Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am J Pathol.. 1994;145:114-125.
[63] Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD. Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem.. 1995;270:3423-3428.
[64] Darby I, Skalli O, Gabbiani G. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest.. 1990;63:21-29.
[65] Sappino AP, Schrürch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulation. Lab Invest.. 1990;63:144-161.
[66] Arora PD, McCulloch CAG. Dependence of collagen remodelling on α-smooth muscle actin expression by fibroblasts. J Cell Physiol.. 1994;159:161-175.
[67] Lafont A, Libby P. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? J Am Coll Cardiol 1998;32:283—285.
[68] Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 1994;89: 2809—2815.
[69] Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB. Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses: an intravascular ultrasound study. Circulation 1997;95:1791—1798.
[70] Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809.
[71] Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991;17:758 —769.
[72] Chen JK, Hoshi H, McKeehan WL. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci USA 1987;84:5287—5291.
[73] Bilder G, Wentz T, Leadley R, Amin D, Byan L, O’Conner B, Needle S, Galczenski H, Bostwick J, Kasiewski C, et al. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-recepto tyrosine kinase inhibitor, RPR101511A. Circulation 1999;99:3292—3299.
[74] Yamasaki M, Hara K, Ikari Y, Kobayashi N, Kozuma K, Ohmoto Y, Oh-Hashi Y, Ako J, Nakajima H, Chiku N, et al. Effects of cilostazol on late lumen loss after Palmaz-Schatz stent implantation. Cathet Cardiovasc Diagn 1998;44:387—391.
[75] Tsuchikane E, Fukuhara A, Kobayashi T, Kirino M, Yamasaki K, Kobayashi T, Izumi M, Otsuji S, Tateyama H, Sakurai M, Awata N. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation 1999; 100:21—26.
[76] Bar-Shavit R, Kahn A, Wilner GD, Fenton JW II. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 1983;220:728 —731.
[77] McNamara CA, Sarembock IJ, Gimple LW, Fenton JW II, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smoothmuscle cells by a proteolytically activated receptor. J Clin Invest 1993;91:94 —98.
[78] Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton JW II, Wilner GD, Vlodavsky I. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul 1990;1:453— 463.
[79] Oberhoff M, Novak S, Herdeg C, Baumbach A, Kranzhofer A, Bohnet A, Horch B, Hanke H, Haase KK, Karsch KR. Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty. Cardiovasc Res 1998;38:751—762.
[80] Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB II. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989;117:777—782.
[81] Gimple LW, Herrmann HC, Winniford M, Mammen E. Usefulness of subcutaneous low molecular weight heparin (ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1999;83: 1524—1529.
[82] Serruys PW, Herrman JP, Simon R, Rutsch W, Bode C, Laarman GJ, van Dijk R, van den Bos AA, Umans VA, Fox KA, for the Helvetica Investigators. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty: Helvetica Investigators. N Engl J Med 1995;333:757—763.
[83] Burchenal JE, Marks DS, Tift Mann J, Schweiger MJ, Rothman MT, Ganz P, Adelman B, Bittl JA. Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty. Am J Cardiol 1998;82:511—515.
[84] Sobue K, Hayashi K, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 1999;190:105-18.
[85] Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 6:369 —375.
[86] Indolfi C, Avvedimento EV, Di Lorenzo E, Esposito G, Rapacciuolo A, Giuliano P, Grieco D, Cavuto L, Stingone AM, Ciullo I, Condorelli G, Chiariello M. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med 1997;3:775—779.
[87] Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium. LabInvest 1983;49:327—333.
[88] Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157—163.
[89] Niebauer J, Schwarzacher SP, Hayase M, Wang B, Kernoff RS, Cooke JP, Yeung AC. Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis. Circulation 1999;100:1830 —1835.
[90] Aikawa M, Sakomura Y, Ueda M, Kimura K, Manabe I, Ishiwata S, et al. Redifferentiation of Smooth Muscle Cells After Coronary Angioplasty Determined via Myosin Heavy Chain Expression. Circulation 1997;96:82—90.
[91] Reidy MA. Thromb Haemost 1993;70:172—6.
[92] Meyrick B, Reid L. Clin Chest Med 1983;4:199—217.
[93] Chaohong Li, Qingbo Xu. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cellular Signaling 2000;12:435-445.
[94] Aplin AE, Howe A, Alahari SK, Juliano RL. Signal transduction and signal modulation by cell adhesion receptors: The role of integrins, Cadherins, immunoglobulin-cell cell adhesion molecules, and selectins. Pharmacol Rev 1998;50:197—263.
[95] Eliceiri BP, Cheresh DA. The role of v integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999;103:1227—30.
[96] Gudi S, Nolan JP, Frangos JA. Modulation of GTPase activity of G proteins by fluid shear stress and phospholipid composition. Proc Natl Acad Sci USA 1998;95:2515—9.
[97] Ishida T, Takahashi M, Corson MA, Berk BC. Ann NY Acad Sci 1997;811:12—23; discussion 23—4.
[98] Gudi SR, Lee AA, Clark CB, Frangos JA. Equibiaxial strain and strain rate stimulate early activation of G proteins in cardiac fibroblasts. Am J Physiol 1998;274:C1424—8.
[99] Gudi SR, Clark CB, Frangos JA. Fluid Flow Rapidly Activates G Proteins in Human Endothelial Cells: Involvement of G Proteins in Mechanochemical Signal Transduction. Circ Res 1996;79:834—9.
[100] Marrero MB, Paxton WG, Schieffer B, Ling BN, Bernstein KE. Angiotensin II Signalling Events Mediated by Tyrosine Phosphorylation. Cell Signal 1996;8:21—6.
[101] Cano E, Mahadevan LC. Paravel signal processing among mammalian MAPKs. Trends Biochem Sci 1995;20:1117-22.
[102] Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999;71:435—78.
[103] Schlaepfer DD, Broome MA, Hunter T. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Mol Cell Biol 1997;17:1702—13.
[104] Guan JL. Matrix Biol 1997;16:195—200.
[105] Li C, Hu Y, Sturm G, Wick G, Xu Q. Ras/Rac-Dependent Activation of p38 Mitogen-Activated Protein Kinases in Smooth Muscle Cells Stimulated by Cyclic Strain Stress. Arterioscler Thromb Vasc Biol 2000;20:e1—e9.
[106] Yamazaki T, Komuro I, Kudoh S, Zou Y, Nagai R, Aikawa R, et al. Role of Ion Channels and Exchangers in Mechanical Stretch—Induced Cardiomyocyte Hypertrophy. Circ Res 1998;82:430—7.
[107] Yamazaki T, Komuro I, Yazaki Y. Signalling Pathways for Cardiac Hypertrophy. Cell Signal 1998;10:693—8.
[108] Hazzalin CA, Cano E, Cuenda A, Barratt MJ, Cohen P, Mahdevan LC. Curr Biol 1996;6:1028—31.
[109] Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA Arteriosclerosis 1990;10:966-990.
[110] 顏正華:中藥學(下),知音出版社,551-556,1991.
[111] 立得中醫研究室編著:活血化瘀的研究,立得出版社,417-425,1992.
[112] 陳可冀、史載祥主編:實用血瘀証學,120-129,1999.
[113] 顏正華:中藥學(上),知音出版社,320-323,1991.
[114] Haraguchi H. Ishikawa H. Shirataki N. Fukuda A. Antiperoxidative activity of neolignans from Magnolia obovata. Journal of Pharmacy & Pharmacology. 1997;49(2):209-12.
[115] Lo YC. Teng CM. Chen CF. Chen CC. Hong CY. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochemical Pharmacology. 1994 ;47(3):549-53.
[116] Hong CY. Huang SS. Tsai SK. Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation. Clinical & Experimental Pharmacology & Physiology. 1996;23(8):660-4.
[117] Lee YM. Hsiao G. Chen HR. Chen YC. Sheu JR. Yen MH. Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats. European Journal of Pharmacology. 2001;422(1-3):159-67.
[118] Tsai SK. Huang CH. Huang SS. Hung LM. Hong CY. Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of L-NAME and aspirin. Pharmacology. 1999; 59(5):227-33.
[119] Shen YC. Sung YJ. Chen CF. Magnolol inhibits Mac-1 (CD11b/CD18)-dependent neutrophil adhesion: relationship with its antioxidant effect. European Journal of Pharmacology. 1998;343(1):79-86.
[120] Teng CM. Chen CC. Ko FN. Lee LG. Huang TF. Chen YP. Hsu HY. Two antiplatelet agents from Magnolia officinalis. Thrombosis Research. 1988 ; 50(6):757-65.
[121] Teng CM. Ko FN. Wang JP. Lin CN. Wu TS. Chen CC. Huang TF. Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs. Journal of Pharmacy & Pharmacology. 1991;43(9):667-9.
[122] Huang YS. Zhang JT. [Antioxidative effect of three water-soluble components isolated from Salvia miltiorrhiza in vitro]. Yao Hsueh Hsueh Pao - Acta Pharmaceutica Sinica. 1992;27(2):96-100.
[123] Chen YH. Du GH. Zhang JT. Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Chung-Kuo Yao Li Hsueh Pao - Acta Pharmacologica Sinica. 2000;21(5):463-6
[124] Chen YH. Lin SJ. Ku HH. Shiao MS. Lin FY. Chen JW. Chen YL. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. Journal of Cellular Biochemistry. 2001; 82(3):512-21.
[125] Amin,N.S. and Holm,C. (1996) In vivo analysis reveals that the interdomain region of the yeast proliferating cell nuclear antigen is important for DNA replication and DNA repair. Genetics 144, 479—493.
[126] Jo´nsson,Z.O. and Hu¨bscher,U. (1997) Proliferating cell nuclear antigen: more than a clamp for DNA polymerases. BioEssays 19, 967—975.
[127] Stillman,B. (1988) Initiation of eukaryotic DNA replication in vitro. BioEssays;9, 56—60.
[128] Jonsson ZO. Hindges R. Hubscher U.(1998) Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen. EMBO Journal. 17(8):2412-25.
[129] Lin SY. Liu JD. Chang HC. Yeh SD. Lin CH. Lee WS.(2002) Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. Journal of Cellular Biochemistry. 84(3):532-44.
[130] Lin SY. Chang YT. Liu JD. Yu CH. Ho YS. Lee YH. Lee WS.(2001) Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Molecular Carcinogenesis. 32(2):73-83.
[131] Hung HH. Chen YL. Lin SJ. Yang SP. Shih CC. Shiao MS. (2001) Chang CH. A salvianolic acid B-rich fraction of Salvia miltiorrhiza induces neointimal cell apoptosis in rabbit angioplasty model. Histology & Histopathology. 16(1):175-83.
[132] Breuss JM. Cejna M. Bergmeister H. Kadl A. Baumgartl G. Steurer S. Xu Z. Koshelnick Y. Lipp J. De Martin R. Losert U. Lammer J. Binder BR.(2002) Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation. 105(5):633-8.
[133] Bellas RE. Lee JS. Sonenshein GE.(1995) Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. Journal of Clinical Investigation. 96(5):2521-7.
[134] Ibe W. Bartels W. Lindemann S. Grosser T. Buerke M. Boissel JP. Meyer J. Darius H.(2001) Involvement of PKC and NF-kappa B in nitric oxide induced apoptosis in human coronary artery smooth muscle cells. Cellular Physiology & Biochemistry. 11(5):231-40.
[135] Ibe W. Bartels W. Lindemann S. Grosser T. Buerke M. Boissel JP. Meyer J. Darius H. (2001) Involvement of PKC and NF-kappaB in nitric oxide induced apoptosis in human coronary artery smooth muscle cells. Cellular Physiology & Biochemistry. 11(5):231-40.
[136] Esterbauer, H., Rotheneder, M., Waeg, G., Striedl, G., and Juergens, G. (1990) biochemical, structural, and functional properties of oxidized low-density lipoproteins. Chem. Res. Toxicol. 3: 77-92.
[137] Bedwell, S., Dean, R. T., and Jessup, W. (1989) The action of defined oxygen-centred free radical on human low-density lipoprotein. Biochem. J. 262; 707-712.
[138] Juergens, G., Hoff, H. F., Chisolm, G. M., and Esterbauer, H. (1987) Modification of human serum low density lipoprotein by oxidation-characterization and pathophysiological implications. Chem. Phys. Lipids 45: 315-336.
[139] Steinbrecher, U. P. (1987) Oxidation of human low density lipoprotein results in derivatisation of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. chem. 2603-3608.
[140] Kaneko, T., Kaji, K., and Matsuo, M. (1988) Cytotoxicities of a linoleic acid hydroperoxide and its related aliphatic aldehydes toward cultured human umbilical vein endothelial cells. 62: 13B-19B.
[141] Haberland, M. E.. Fong, D., and Cheng, L. (1988) malondialdehyd altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241 :215-218.
[142] Rosenfeld, M. E., Palinski, W., Yla-Herttuala, S., Butler, S., and Witztum, J. L. (1990) Distribution of oxidation specific lipid-protein adducts and apolipoprotein b in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10: 336-349.
[143] Palinski, W., Rosenfeld, M. E., Yla-Herttuala, S., Gurtner, G, C., Socher, S.S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., and Witztum, J. L. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86: 1372-13776.
[144] Shen CM. Mao SJ. Huang GS. Yang PC. Chu RM. (2001) Stimulation of smooth muscle cell proliferation by ox-LDL- and acetyl LDL-induced macrophage-derived foam cells. Life Sciences. 70(4):443-52.
[145] Roberts MJ. Young IS. Trouton TG. Trimble ER. Khan MM. Webb SW. Wilson CM. Patterson GC. Adgey AA. (1990) Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet. 336(8708):143-5.
[146] Zhao SP. Xu DY. (2000) Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells. Clinica Chimica Acta. 296(1-2):121-33.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top